Shilpa Medicare Limited

Report Side Effects

Report any adverse drug reactions (ADRs) or side effects you may have experienced. Your report helps us ensure the safety and efficacy of our pharmaceutical products.

Adverse Drug Reaction (ADR) Reporting Form

Adverse Drug Reaction (ADR) Information

1

What is ADR?

Any response to drug, which is noxious and unintended which occurs at doses normally used for treatment, prophylaxis, diagnosis, or modification of physiological function.

दवा के प्रति कोई भी प्रतिक्रिया, जो हानिकारक और अनपेक्षित है, जो आमतौर पर उपचार, प्रोफिलैक्सिस, निदान या शारीरिक कार्य में संशोधन के लिए उपयोग की जाने वाली खुराक पर होती है।

2

What to report?

To report an adverse event(s) experienced by consumer(s)/Patient(s) due to Shilpa's products (if any) by using below ADR form.

शिल्पा के उत्पादों (यदि कोई हो) के कारण उपभोक्ता/रोगी द्वारा अनुभव की गई किसी प्रतिकूल घटना की रिपोर्ट करने के लिए नीचे दिए गए एडीआर फॉर्म का उपयोग करें।

3

Who can report an ADR?

All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.

सभी उपभोक्ताओं या रोगियों को सलाह दी जाती है कि वे दवाओं या किसी स्वास्थ्य मामले/चिकित्सा आपात स्थिति पर सलाह के लिए अपने डॉक्टर या स्वास्थ्य देखभाल पेशेवर से संपर्क करें।

4

How to report ADR?

For reporting Adverse events and Product quality complaints, please send an email or call us as per the details provided in below table.

प्रतिकूल घटनाओं और उत्पाद की गुणवत्ता की शिकायतों की रिपोर्ट करने के लिए, कृपया नीचे दी गई तालिका में दिए गए विवरण के अनुसार एक ईमेल भेजें या हमें कॉल करें।

Contact Details for Reporting

RegionEmailTelephone
GlobalPharmacovigilance@shilpamedicare.com

Toll free (USA): +1-888-557-1212

EU: +34-950387986

Other regions: +91 9866307771(Calling & WhatsApp)

IndiaPharmacovigilance@shilpamedicare.com

Toll Free: 1800 180 3024

(PvPI: 9:00 AM to 5:30 PM, Monday-Friday)

Or: +91 9866307771(Calling & WhatsApp)

Report Side Effects

दावाओं की सुरक्षा रिपोर्टिंग (Drug Safety Reporting)

Reporter Information

OR

Suspected Adverse Reaction

Action Taken

Suspect Medication(s)

Note: All information provided will be kept confidential and used solely for pharmacovigilance purposes. For any queries, please contact us at drugsafety@vbshilpa.com

Corporate Office

Shilpa Medicare Limited

#12-6-214/A1, Hyderabad Road,
Raichur – 584 135,
Karnataka, India

We aim to respond to all enquiries within 24-48 business hours.

Our Locations

Our state-of-the-art manufacturing and research facilities across India

API Unit I

Raichur

Plot No. 4A, Deosugur Industrial Area, Shaktinagar – 584 170, Karnataka

Formulation Unit

Jadcherla

Plot No: S20 to S24A, Green Industrial Park, Jadcherla, Telangana - 509 301

API Unit II & R&D

Raichur

Plot No.33, 33A & 40-47, Raichur Industrial Growth Centre, Raichur - 584 134, Karnataka

Formulation R&D Centre

Bangalore

Plot No. 29/A, Phase IV, Averahalli Industrial Area, Bengaluru - 560111

Shilpa Therapeutics

Hyderabad

118, I.D.A, Phase III, Cherlapally, Hyderabad - 500 051, Telangana

Analytical Services Lab

Hyderabad

Plot no 79, Road No 15, IDA Mallpur, Nacharam, Hyderabad - 500 076, Telangana